Clinical trial
Case Series of Continuously-infused Amphotericin-B and Follow-up Voriconazole Therapy for Severe Blastomycosis Pulmonary Infections
NCT02283905 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Case Series of Continuously-infused Amphotericin-B and Follow-up Voriconazole Therapy for Severe Blastomycosis Pulmonary Infections
- Lead sponsor
- University of Manitoba
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- June 30, 2015
- Completion date
- September 25, 2020
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.